| 000 | 01606 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513231544.0 | ||
| 264 | 0 | _c20010201 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.2000.tb06950.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLara-Marquez, M L | |
| 245 | 0 | 0 |
_aVasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _c2000 |
||
| 300 |
_a45-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aMonocytes _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Vasoactive Intestinal Peptide _xgenetics |
| 650 | 0 | 4 | _aReceptors, Vasoactive Intestinal Peptide, Type II |
| 650 | 0 | 4 | _aReceptors, Vasoactive Intestinal Polypeptide, Type I |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aO'Dorisio, M S | |
| 700 | 1 | _aKaracay, B | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 921 _gp. 45-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.2000.tb06950.x _zAvailable from publisher's website |
| 999 |
_c11132057 _d11132057 |
||